DF Dent & Co’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.59M | Hold |
25,317
| – | – | 0.03% | 139 |
|
|
2025
Q4 | $1.68M | Buy |
25,317
+5,496
| +28% | +$355K | 0.02% | 144 |
|
|
2025
Q3 | $1.33M | Sell |
19,821
-12,911
| -39% | -$1.02M | 0.02% | 161 |
|
|
2025
Q2 | $2.86M | Sell |
32,732
-78
| -0.2% | -$6.11K | 0.04% | 120 |
|
|
2025
Q1 | $2.24M | Sell |
32,810
-4,948
| -13% | -$404K | 0.03% | 128 |
|
|
2024
Q4 | $2.94M | Buy |
37,758
+5,088
| +16% | +$377K | 0.04% | 124 |
|
|
2024
Q3 | $2.19M | Buy |
32,670
+6,410
| +24% | +$526K | 0.03% | 131 |
|
|
2024
Q2 | $2.98M | Sell |
26,260
-40
| -0.2% | -$5.06K | 0.04% | 115 |
|
|
2024
Q1 | $3.65M | Sell |
26,300
-1
| -0% | -$126 | 0.04% | 113 |
|
|
2023
Q4 | $3.26M | Buy |
26,301
+13,739
| +109% | +$1.4M | 0.04% | 106 |
|
|
2023
Q3 | $1.17M | Sell |
12,562
-57
| -0.5% | -$6.42K | 0.02% | 142 |
|
|
2023
Q2 | $1.62M | Sell |
12,619
-3
| -0% | -$363 | 0.02% | 130 |
|
|
2023
Q1 | $1.47M | Hold |
12,622
| – | – | 0.02% | 133 |
|
|
2022
Q4 | $1.43M | Sell |
12,622
-26
| -0.2% | -$2.85K | 0.02% | 129 |
|
|
2022
Q3 | $1.02M | Buy |
+12,648
| New | +$1.07M | 0.02% | 137 |
|
|
2020
Q2 | – | Sell |
-4,036
| Closed | -$272K | – | 198 |
|
|
2020
Q1 | $272K | Sell |
4,036
-132,440
| -97% | -$8.24M | 0.01% | 177 |
|
|
2019
Q4 | $7.46M | Sell |
136,476
-31,832
| -19% | -$1.51M | 0.13% | 66 |
|
|
2019
Q3 | $6.28M | Buy |
168,308
+2,144
| +1% | +$83.3K | 0.11% | 69 |
|
|
2019
Q2 | $6.22M | Sell |
166,164
-236
| -0.1% | -$7.42K | 0.11% | 72 |
|
|
2019
Q1 | $4.96M | Buy |
166,400
+116,208
| +232% | +$4.08M | 0.1% | 82 |
|
|
2018
Q4 | $1.5M | Buy |
50,192
+3,824
| +8% | +$121K | 0.04% | 112 |
|
|
2018
Q3 | $1.66M | Sell |
46,368
-12,056
| -21% | -$374K | 0.03% | 122 |
|
|
2018
Q2 | $1.39M | Buy |
58,424
+608
| +1% | +$12.9K | 0.03% | 128 |
|
|
2018
Q1 | $1.07M | Buy |
57,816
+2,804
| +5% | +$41.5K | 0.02% | 142 |
|
|
2017
Q4 | $789K | Sell |
55,012
-248,412
| -82% | -$3.23M | 0.02% | 124 |
|
|
2017
Q3 | $3.71M | Buy |
303,424
+247,048
| +438% | +$4.37M | 0.1% | 58 |
|
|
2017
Q2 | $1.03M | Buy |
56,376
+17,820
| +46% | +$329K | 0.03% | 89 |
|
|
2017
Q1 | $817K | Buy |
38,556
+2,416
| +7% | +$47.2K | 0.02% | 90 |
|
|
2016
Q4 | $539K | Buy |
+36,140
| New | +$640K | 0.02% | 119 |
|
Other funds holding DXCM
VCM
VPM
DF Dent & Co's DXCM Position: Q1 2026 in Review
DF Dent & Co held its DexCom (DXCM) position steady in Q1 2026 at 25,317 shares worth $1.59M. The position accounts for 0.03% of the portfolio, ranked #139.
DF Dent & Co first reported a position in DXCM in Q4 2016 and has held it in 29 quarters since. The position peaked at $7.46M in Q4 2019. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- DF Dent & Co held 25,317 shares of DexCom worth $1.59M as of Q1 2026.
- DF Dent & Co left its DexCom share count unchanged in Q1 2026.
- DexCom made up 0.03% of DF Dent & Co's portfolio in Q1 2026, its #139 holding.
- DF Dent & Co first reported a position in DexCom in Q4 2016 and has held it in 29 quarters since.
- DF Dent & Co's DexCom position peaked at $7.46M in Q4 2019.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.